Publications To Date


    Filter Publications

    PAGE 1 OF 8 | DISPLAYING 1 - 15 OF 120 RESULTS

    Tan T.Z. et. al., Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer., 10.1002/path.5191, J. Pathol., Oct 30, 2018

    Grellety T. et. al., Enhancing abiraterone acetate efficacy in androgen receptor-positive triple negative breast cancer: Chk1 as a potential target., 10.1158/1078-0432.CCR-18-1469, Clin. Can. Res., Oct 23, 2018

    Ciavarella S. et. al., Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue., 10.1093/annonc/mdy450, Ann. Oncol., Oct 11, 2018

    Xie Y. et. al., Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer., 10.1158/1078-0432.CCR-17-2543., Clin. Can. Res., Oct 04, 2018

    Schultz S. et. al., Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers, 10.1186/s12920-018-0403-5, BMC. Med. Genomics, Sep 20, 2018

    Liu J. et. al., Aberrant differential expression of EZH2 and H3K27me3 in extranodal NK/T-cell lymphoma, nasal type is associated with disease progression and prognosis., 10.1016/j.humpath.2018.08.025, Hum. Pathol., Sep 12, 2018

    Su B. et. al., hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis, 10.3892/or.2018.6690, Oncol Rep., Sep 07, 2018

    Sugio T. et. al., Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS, 10.1182/bloodadvances.2018018754, Blood Adv., Sep 07, 2018

    Burgo M.A. et. al., Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma, 10.1172/jci.insight.120750, JCI Insight, Sep 06, 2018

    Kim H.K. et. al., Discordance of the PAM50 Intrinsic Subtypes Compared with IHC-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance., 10.4143/crt.2018.342, Cancer Res. Treat., Sep 05, 2018

    Buus R. et. al., Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer, 10.1186/s13058-018-1040-9, Breast Can. Res., Sep 04, 2018

    Saad A.G. et. al., nCounter NanoString Assay Shows Variable Concordance With Immunohistochemistry-based Algorithms in Classifying Cases of Diffuse Large B-Cell Lymphoma According to the Cell-of-Origin., 10.1097/PAI.0000000000000696, Appl Immunohistochem Mol Morphol. , Sep 01, 2018

    Moyes K.W. et. al., Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma., 10.1080/2162402X.2018.1507668., Oncoimmunology, Aug 27, 2018

    Sheth J. et. al., Sarcoma Subgrouping by Detection of Fusion Transcripts Using NanoString nCounter Technology., 10.1177/1093526618790747, Pediatr. Dev. Pathol., Aug 08, 2018

    Dahl M. et. al., Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies,, Lab. Invest., Aug 07, 2018